Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASOAF perioperative vasopressin trial in cardiovascular surgery
jRCTs041230034Recruiting
- Start
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronary arteriosclerosis, aortopathy and aortic valve disease (AVD) comparing Vasopressin with Placebo (2 arms). Primary endpoint: Postoperative atrial fibrillation within 3 days. Started Mar 2024; status: recruiting.
02
Drugs
vasopressin
03
Conditions
coronary arteriosclerosisaortopathyaortic valve disease (AVD)
Beyond the preview
Go deeper on jRCTs041230034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230034.